72 Orally Dissolving, Thin Film Dexmedetomidine (BXCL501) Demonstrates Significant Reduction in Agitation Across a Range of Agitation Severity in Patients With Schizophrenia and Bipolar Disorder

Saved in:

Bibliographic Details
Published in	Annals of emergency medicine Vol. 78; no. 4; pp. S29 - S30
Main Authors	Zeller, S., Benabou, R., Risinger, R., Robison, H.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.10.2021
Online Access	Get full text

Loading…

More Information
ISSN:	0196-0644 1097-6760
DOI:	10.1016/j.annemergmed.2021.09.081